Skip to main content
main-content

04.06.2022 | Original Article

Methyl (S)-2-(1–7 (5-fluoropentyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoate (5F-MDMB-PICA) intoxication in a child with identification of two new metabolites (ultra-high-performance liquid chromatography–tandem mass spectrometry)

verfasst von: Paweł Szpot, Karolina Nowak, Olga Wachełko, Kaja Tusiewicz, Agnieszka Chłopaś-Konowałek, Marcin Zawadzki

Erschienen in: Forensic Toxicology

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Methyl (S)-2-(1–7 (5-fluoropentyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoate (5F-MDMA-PICA) intoxication in 1.5-year-old child was presented, together with diagnostic parameters discussion and 5F-MDMB-PICA determination in biological material. Furthermore, 5F-MDMB-PICA metabolites were identified in a urine sample as markers of exposure in situation when a parent compound is not present in specimens.

Methods

Drugs and metabolites were extracted from serum and urine with ethyl acetate both under alkaline (pH 9) and acidic (pH 3) conditions. Hair, after decontamination and pulverization, were incubated with methanol (16 h, 60 °C). The analysis was carried out using ultra-high-performance liquid chromatography–tandem mass spectrometry. For the identification of 5F-MDMB-PICA metabolites, an urine sample was precipitated with cold acetonitrile. Analysis was performed using ultra-high-performance liquid chromatograph with quadrupole time-of-flight mass spectrometer.

Results

5F-MDMB-PICA was determined only in serum sample at concentration of 298 ng/mL. After 1 year, when analysis was repeated, concentration of synthetic cannabinoid in the same sample was only 17.6 ng/mL which revealed high instability of 5F-MDMB-PICA in serum sample. Eight 5F-MDMB-PICA metabolites were identified in urine sample, including two potentially new ones with m/z 391.18964 and m/z 275.14016.

Conclusions

Toxicological analysis confirmed a 1.5-year-old boy intoxication with 5F-MDMB-PICA. Besides the parent drug, metabolites of 5F-MDMB-PICA were identified, including two potentially new ones, together with possible metabolic reactions which they resulted from. Metabolites determination could serve as a marker of 5F-MDMB-PICA exposure when no parent drug is present in biological material.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
13.
Zurück zum Zitat Logan BK, Gurney SMR, Scott KS, Kacinko SL, Presley BC, Logan BK (2014) Pharmacology, toxicology, and adverse effects of synthetic cannabinoid drugs. Forensic Sci Rev 26:53–78 PubMed Logan BK, Gurney SMR, Scott KS, Kacinko SL, Presley BC, Logan BK (2014) Pharmacology, toxicology, and adverse effects of synthetic cannabinoid drugs. Forensic Sci Rev 26:53–78 PubMed
31.
Zurück zum Zitat Wargo K, Geveden BN, McConnel VJ (2007) Cannabinoid-induced pancreatitis: a case series. J Pancreas 8:579–583 Wargo K, Geveden BN, McConnel VJ (2007) Cannabinoid-induced pancreatitis: a case series. J Pancreas 8:579–583
33.
Zurück zum Zitat Templeton K, Omar M, Narahari P (2019) Acute synthetic cannabinoid induced pancreatitis and psychosis. In: Poster presented at: APA alabama state conference, October 2019 Templeton K, Omar M, Narahari P (2019) Acute synthetic cannabinoid induced pancreatitis and psychosis. In: Poster presented at: APA alabama state conference, October 2019
Metadaten
Titel
Methyl (S)-2-(1–7 (5-fluoropentyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoate (5F-MDMB-PICA) intoxication in a child with identification of two new metabolites (ultra-high-performance liquid chromatography–tandem mass spectrometry)
verfasst von
Paweł Szpot
Karolina Nowak
Olga Wachełko
Kaja Tusiewicz
Agnieszka Chłopaś-Konowałek
Marcin Zawadzki
Publikationsdatum
04.06.2022
Verlag
Springer Nature Singapore
Erschienen in
Forensic Toxicology
Print ISSN: 1860-8965
Elektronische ISSN: 1860-8973
DOI
https://doi.org/10.1007/s11419-022-00629-7

Neu im Fachgebiet Rechtsmedizin

09.06.2022 | Epstein-Barr-Virus | Schwerpunkt: Nichtneoplastische Hämatopathologie

EBV-assoziierte lymphoproliferative Erkrankungen

09.06.2022 | Myelodysplastische Syndrome | Schwerpunkt: Nichtneoplastische Hämatopathologie

Medikamentös induzierte Knochenmarkveränderungen

Open Access 19.05.2022 | Schwerpunkt: Nichtneoplastische Hämatopathologie

Differenzialdiagnose reaktiver Zytopenien